CVI Earnings

CVI reported its earnings on 2026-02-18, showcasing a revenue of 1.81B against an estimate of 1.74B, resulting in a 4.02% surprise. The EPS was -0.8, surpassing the expected -0.84 by 4.76%. The stock experienced a -3.44% price change on the earnings day and a -2.91% change over the next five days, reflecting market reactions to the results.

Following CVI's earnings announcement on 2026-02-18, the stock price moved by -3.44% on the day of the release. Over the subsequent five days, it saw a -2.91% change. Historically, CVI's stock price tends to shift by an average of -0.94% in the 10 days leading up to earnings and -3.22% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate CVI's annual revenue to reach 1.66B, while the EPS is projected at 0.19. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CVI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CVI's stock price typically moves by -0.94% in the 10 days before its earnings and -3.22% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.19 and revenue of 1.66B.

Despite some positive aspects like increased Petroleum Segment Adjusted EBITDA and strategic expansion plans, the overall sentiment is negative. The company reported a significant net loss and breakeven cash flow, with no share repurchase program or dividend reinstatement. The Q&A revealed management's avoidance of providing specific targets and plans, along with concerns about high RIN prices and delayed fertilizer segment recovery. These factors, combined with the lack of strong shareholder return initiatives, suggest a negative stock price reaction.